Aotaphenazine, a rare hydrophenazine, targets topoisomerase II with anticancer efficacy: In silico to in vitro evidence

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Aotaphenazine, a rare hydrophenazine, targets topoisomerase II with anticancer efficacy: In silico to in vitro evidence2025 · 9 citations
2. 2Integrated experimental and computational exploration of 1,8-naphthyridine hydrazones as promising topoisomerase II-targeting anticancer agents2026
3. 3New 1,3,4‒oxadiazole Quinazolines as Potential Anticancer Agents: Design, Synthesis, Biological Evaluation, and In silico Studies2024
4. 4Abstract 1731 More Efficient Inhibition of Topoisomerase II Alpha with (1E,4E)-1,7-Bis(4-hydroxyphenyl)Hepta-1,4-Dien-3-One2024
5. 5Discovery of Bis-Thiourea Derivatives as Human DNA Topoisomerase IIα Inhibitors with Potent Anticancer Effects2026